Ian Cook
#119,801
Most Influential Person Now
American psychiatrist
Ian Cook 's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Ian Cook Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ian Ainsworth Cook is an American psychiatrist. He is an associate professor of Psychiatry and Biobehavioral Sciences at the University of California, Los Angeles's David Geffen School of Medicine. He is also a research scientist at the UCLA Neuropsychiatric Institute and the Brain Research Institute at UCLA. He serves as director of the UCLA Depression Research Program and associate director of the UCLA Laboratory of Brain, Behavior, and Pharmacology. Cook holds the Joanne and George Miller & Family Chair in Depression Research.
Ian Cook 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Practice guideline for the assessment and treatment of patients with suicidal behaviors. (2003) (488)
- Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. (2004) (464)
- Changes in brain function of depressed subjects during treatment with placebo. (2002) (382)
- Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression. (2017) (336)
- Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. (2011) (322)
- American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. (2007) (302)
- Yoga as a Complementary Treatment of Depression: Effects of Traits and Moods on Treatment Outcome (2007) (299)
- Assessing the accuracy of topographic EEG mapping for determining local brain function. (1998) (298)
- TRANSCRANIAL MAGNETIC STIMULATION (TMS) FOR MAJOR DEPRESSION: A MULTISITE, NATURALISTIC, OBSERVATIONAL STUDY OF ACUTE TREATMENT OUTCOMES IN CLINICAL PRACTICE (2012) (258)
- Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia. (1992) (244)
- Treatment of patients with substance use disorders, second edition. American Psychiatric Association. (2006) (216)
- Executive dysfunction predicts nonresponse to fluoxetine in major depression. (2000) (214)
- Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy (2013) (189)
- Early Changes in Prefrontal Activity Characterize Clinical Responders to Antidepressants (2002) (185)
- Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. (2005) (184)
- Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures. (1993) (182)
- Resting-State Quantitative Electroencephalography Reveals Increased Neurophysiologic Connectivity in Depression (2012) (177)
- Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: Results of the BRITE-MD study (2009) (173)
- Residual Symptoms in Depressed Outpatients Who Respond by 50% But Do Not Remit to Antidepressant Medication (2011) (159)
- Relationship between brain electrical activity and cortical perfusion in normal subjects (1999) (158)
- Health-related quality of life in depression: a STAR*D report. (2010) (148)
- Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression (2009) (136)
- Biomarkers to Predict Antidepressant Response (2010) (127)
- Cordance: A New Method for Assessment of Cerebral Perfusion and Metabolism Using Quantitative Electroencephalography (1994) (124)
- A web-based data management system to improve care for depression in a multicenter clinical trial. (2002) (116)
- A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. (2014) (115)
- Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder (2009) (113)
- The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder (2013) (107)
- fMRI activation in the amygdala and the orbitofrontal cortex in unmedicated subjects with major depressive disorder (2010) (107)
- Cognitive, behavioral, and autonomic correlates of mind wandering and perseverative cognition in major depression (2015) (106)
- Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: An Updated Systematic Review and Meta-analysis (2016) (106)
- Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. (2004) (106)
- Reduced EEG coherence in dementia: State or trait marker? (1994) (103)
- Monoamine Oxidase A and Catechol-O-Methyltransferase Functional Polymorphisms and the Placebo Response in Major Depressive Disorder (2009) (102)
- Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. (2005) (93)
- Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report (2009) (88)
- Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression (2015) (86)
- Synaptic dysfunction in Alzheimer's disease: clinical assessment using quantitative EEG (1996) (84)
- Practice guideline for the treatment of patients with nicotine dependence. American Psychiatric Association. (1996) (84)
- Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. (2006) (79)
- Treatment of patients with substance use disorders, second edition. American Psychiatic Association. (2006) (78)
- Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression. (2014) (78)
- Baroreflex mechanisms in major depression (2007) (77)
- Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals (2003) (77)
- Effect of white matter disease on functional connections in the aging brain. (1994) (76)
- Trigeminal nerve stimulation in major depressive disorder: Acute outcomes in an open pilot study (2013) (76)
- Neurophysiologic predictors of treatment response to fluoxetine in major depression (1999) (75)
- The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. (2007) (74)
- Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. (2005) (74)
- Brain Electrical Source Differences between Depressed Subjects and Healthy Controls (2008) (72)
- Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects. (2002) (70)
- Brain structure and function and the outcomes of treatment for depression. (1997) (70)
- Double-Blind, Sham-Controlled, Pilot Study of Trigeminal Nerve Stimulation for Attention-Deficit/Hyperactivity Disorder. (2019) (66)
- Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. (2005) (66)
- Trigeminal nerve stimulation in major depressive disorder: First proof of concept in an open pilot trial (2011) (63)
- Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. (2010) (63)
- Prefrontal changes and treatment response prediction in depression. (2001) (63)
- A new paradigm for the prediction of antidepressant treatment response (2009) (63)
- Site Versus Centralized Raters in a Clinical Depression Trial: Impact on Patient Selection and Placebo Response (2010) (61)
- Do atypical features affect outcome in depressed outpatients treated with citalopram? (2010) (60)
- Midline and right frontal brain function as a physiologic biomarker of remission in major depression (2009) (59)
- Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation). (2014) (54)
- Longitudinal progression of subclinical structural brain disease in normal aging. (2004) (54)
- Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers (2004) (52)
- Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression (2004) (52)
- Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments (2015) (51)
- A genome-wide association study of a sustained pattern of antidepressant response. (2013) (51)
- Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (2019) (50)
- White Matter Injury, Neural Connectivity and the Pathophysiology of Psychiatric Disorders (2002) (48)
- Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. (2011) (47)
- Trigeminal Nerve Stimulation for Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder (2016) (46)
- Trigeminal nerve stimulation: seminal animal and human studies for epilepsy and depression. (2011) (42)
- Influence of Age, Gender, Health Status, and Depression on Quantitative EEG (2005) (41)
- Regional Brain Activation With Advertising Images (2011) (40)
- Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder (2011) (39)
- Heart rate variability and treatment outcome in major depression: a pilot study. (2014) (39)
- An Eight-week, Open-trial, Pilot Feasibility Study of Trigeminal Nerve Stimulation in Youth With Attention-deficit/Hyperactivity Disorder (2015) (38)
- Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment (2010) (36)
- Aging and brain activation with working memory tasks: an fMRI study of connectivity (2007) (36)
- Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder (2019) (34)
- Neurophysiologic Correlates of Side Effects in Normal Subjects Randomized to Venlafaxine or Placebo (2005) (34)
- Assessment of cerebral perfusion using quantitative EEG cordance (1994) (33)
- Ancient Architectural Acoustic Resonance Patterns and Regional Brain Activity (2008) (33)
- Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder (2014) (32)
- The Antidepressant Treatment Response Index and Treatment Outcomes in a Placebo-Controlled Trial of Fluoxetine (2011) (32)
- Biomarkers in Psychiatry : Potentials, Pitfalls, and Pragmatics (2008) (32)
- Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice (2013) (32)
- Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*D. (2008) (29)
- Altered cerebral energy utilization in late life depression. (1998) (28)
- Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? (2013) (28)
- Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. (2013) (28)
- Changes in Brain Function during Administration of Venlafaxine or Placebo to Normal Subjects (2008) (28)
- Neurophysiologic changes during estrogen augmentation in perimenopausal depression. (2007) (27)
- Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. (2009) (27)
- Use of Clinical Neurophysiology for the Selection of Medication in the Treatment of Major Depressive Disorder: The State of the Evidence (2009) (26)
- QEEG Measures in Huntington's Disease: A Pilot Study (2010) (24)
- Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy (2019) (24)
- Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder. (2017) (22)
- Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder? (2014) (22)
- Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study (2002) (21)
- Electronic source materials in clinical research: acceptability and validity of symptom self-rating in major depressive disorder. (2007) (21)
- Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder (2018) (21)
- Quantitative electroencephalographic correlates of psychosis in Alzheimer disease. (2000) (20)
- Psychiatric evaluation of adults: Second edition (2006) (20)
- Trigeminal Nerve Stimulation (TNS) for Generalized Anxiety Disorder: A Case Study (2015) (19)
- Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. (2009) (19)
- Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression. (2010) (19)
- Does the Clinical Course of Depression Determine Improvement in Symptoms and Quality of Life? (2006) (18)
- The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder (2015) (18)
- Evaluation of Quantitative EEG by Classification and Regression Trees to Characterize Responders to Antidepressant and Placebo Treatment (2011) (18)
- Trigeminal Nerve Stimulation (TNS) for Post-traumatic Stress Disorder: A Case Study (2015) (17)
- Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project. (2014) (16)
- Does prior antidepressant treatment of major depression impact brain function during current treatment? (2012) (15)
- Pretreatment Neurophysiologic Function and ECT Response in Depression (2004) (15)
- Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition. (2006) (15)
- Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder (2015) (14)
- The potential use of trigeminal nerve stimulation in the treatment of epilepsy. (2015) (13)
- Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington’s Disease: Are They Fit-for-Purpose for Treatment Development? (2017) (13)
- Brain functional changes during placebo lead‐in and changes in specific symptoms during pharmacotherapy for major depression (2009) (13)
- Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study (2014) (12)
- Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes? (2013) (11)
- Predictors of response to synchronized transcranial magnetic stimulation for major depressive disorder (2018) (11)
- Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part II: Two-Year Follow-Up of Patients With Depression. (1994) (11)
- Trigeminal Nerve Stimulation (TNS) for Panic Disorder: An Open Label Proof-of-Concept Trial (2016) (10)
- The Effectiveness and Risks of Cranial Electrical Stimulation for the Treatment of Pain, Depression, Anxiety, PTSD, and Insomnia: A Systematic Review (2018) (9)
- Transcranial Magnetic Stimulation for Anxiety Symptoms: An Updated Systematic Review and Meta-Analysis (2016) (9)
- Brain Activity and Clinical Outcomes in Adults With Depression Treated With Synchronized Transcranial Magnetic Stimulation: An Exploratory Study (2019) (8)
- Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part I: Cross-Sectional and Longitudinal Assessment of Patients With Dementia. (1994) (8)
- Amygdala Lateralization at Rest and during Viewing of Neutral Faces in Major Depressive Disorder Using Low-Resolution Brain Electromagnetic Tomography (2010) (8)
- Trigeminal Nerve Stimulation (TNS) for the Treatment of Irritable Bowel Syndrome in an Elderly Patient with Major Depressive Disorder: A Case Study (2015) (8)
- Quantitative EEG Effects of Nicotine Replacement by Cigarette Smoking1 (1998) (7)
- Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder? (2017) (7)
- Trigeminal nerve stimulation (TNS) for posttraumatic stress disorder and major depressive disorder: An open-label proof-of-concept trial (2016) (7)
- Reply to Kuo and Tsai (2010) (5)
- Guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder (2004) (5)
- Trigeminal Nerve Stimulation (TNS) for Major Depressive Disorder in the Elderly: An Open Label Proof-of-Concept Trial (2016) (5)
- Manipulation of Cigarette Craving with Transcranial Magnetic Stimulation (2011) (4)
- Cellular Physiology and Electromagnetic Fields: Cellular Communication, Human Communication (1990) (4)
- Time Course of Changes in Peripheral Blood Gene Expression During Medication Treatment for Major Depressive Disorder (2019) (4)
- Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial. (2020) (3)
- Hypnotic Discontinuation Using a Blinded (Masked) Tapering Approach: A Case Series (2019) (3)
- Neurophysiologic Correlates of Headache Pain in Subjects With Major Depressive Disorder (2017) (3)
- Reply to “Transcutaneous electric currents to target the peripheral and central nervous system in children with attention deficit hyperactivity disorder” (2019) (3)
- Everyday Mishaps and Lapses in Ethics, Professionalism, and Self-Care: A Faculty Development Workshop (2016) (2)
- Double-Blind, Sham-Controlled, Pilot Study of Trigeminal Nerve Stimulation for ADHD (2019) (2)
- What Shapes Depressed Individuals ' Pre-Treatment Expectation in Antidepressant Clinical Trials ? (2018) (2)
- Synergistic effects of ketamine and theta burst stimulation in the treatment of major depressive disorder (MDD) (2017) (2)
- Comment on ‘The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants’ (2012) (1)
- Personalizing Treatment for Late-Life Depression: Research Approaches (2013) (1)
- The Future of Psychiatry Commission. (2018) (1)
- Neurocognitive Disorders in Geriatric Psychiatry. (2017) (1)
- Complementary and Integrative Treatments. (2018) (1)
- Benefits and Harms of Cranial Electrical Stimulation (2018) (1)
- Trigeminal Nerve Stimulation May Not Be Effective for the Treatment of Refractory Partial Seizures (2013) (1)
- Recurrent Major Depressive Disorder of a Young Woman. (2016) (1)
- Effects of trigeminal nerve stimulation on regional brain activity in depression (2011) (1)
- Synchronized Transcranial Magnetic Stimulation (sTMS) Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression (2015) (1)
- Emerging Therapies in Psychiatry. (2018) (1)
- EEG Spectral Features in Sleep of Autism Spectrum Disorders in Children with Tuberous Sclerosis Complex (2019) (0)
- Thermal effects of Theta Burst Stimulation on Skin with Tattoos (2019) (0)
- GUIDEL INE FOR THE Treatment of Patients With Obsessive-Compulsive Disorder WORK GROUP ON OBSESSIVE-COMPULSIVE DISORDER (2007) (0)
- CNS volume 18 issue 6 Cover and Front matter (2013) (0)
- P.2.g.007 Biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) (2007) (0)
- Clinical research Intermediate phenotypes and biomarkers of treatment outcome in major depressive (2014) (0)
- Patient Management Exercise A Person-Centered Approach to Treatment (2010) (0)
- Patient Management Exercise: Late-Life Psychiatry (2013) (0)
- Computer aided evaluation of early neoplasms (1987) (0)
- Patient Management Exercise: Psychopharmacology (2014) (0)
- Anemia in general practice. Laboratory services. (1967) (0)
- Our archaeoacoustic back pages (2017) (0)
- Brain activity and clinical outcomes in adults with depression treated with synchronized transcranial magnetic stimulation (sTMS): an exploratory study (2019) (0)
- Neuroscience in Clinical Care. (2019) (0)
- Dr McClintock and Colleagues Reply. (2018) (0)
- P.1.126 Changes in brain function associated withclinical response to duloxetine (2004) (0)
- Patient Management Exercise: Psychopharmacology: Treatment-Resistant Disorders (2010) (0)
- Psychotherapy: Use in Persistent Anxiety and Depression. (2018) (0)
- Biopotentials and Regeneration in Planaria (2017) (0)
- Patient Management Exercise: Experiencing Psychosis (2012) (0)
- Xanadu and Mood Stabilization. (2019) (0)
- Patient Management Exercise for Psychosomatic Medicine (2009) (0)
- Corrigendum to ‘Neurophysiologic predictors of treatment response to fluoxetine in major depression’ [Psychiatry Research 85 (1999) 263–273] 1 PII of original article: S0165-1781(99)00010-4 1 (2000) (0)
- Patient Management Exercise (2012) (0)
- Author ' s personal copy Antidepressant response trajectories and quantitative electroencephalography ( QEEG ) biomarkers in major depressive disorder (2010) (0)
- Works Title Baroreflex mechanisms in major depression (2007) (0)
- Patient Management Exercise: Disorders of Sleep (2009) (0)
- Exercise HILD A ND A DOLESCENT P SYCHIATRY (2012) (0)
- Patient Management Exercise: Bipolar Disorder: All the World Was Alive (2015) (0)
- Patient Management Exercise for Bipolar Disorder (2011) (0)
- EEG Spectral Features in Sleep of Autism Spectrum Disorders in Children with Tuberous Sclerosis Complex (2019) (0)
- Postpartum Depression. (2020) (0)
- Safety and Efficacy of Synchronized Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder (2015) (0)
- Exercise A NXIETY D ISORDERS (2011) (0)
- Intrasession Reliability of Single and Paired Pulse TMS Evoked From the Biceps Brachii Representation of the Human Motor Cortex (2015) (0)
- Effects of adjunctive trigeminal nerve stimulation in major depressive disorder in a dose-ranging trial (2015) (0)
- CNS infections (1983) (0)
- Patient Management Exercise: Psychosomatic Medicine and Integrated Care (2013) (0)
- O16 Shifts in mean peak oscillatory frequency during repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (2017) (0)
- Patient Management Exercise for Genetics and Genomics (2010) (0)
- Extracranial implantable devices and systems for the treatment of neuropsychiatric disorders (2010) (0)
- Title Role of pill-taking , expectation and therapeutic alliance in the placebo response in clinical trials for major depression Permalink (2014) (0)
- Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder (2015) (0)
- Patient Management Exercise for Anxiety Disorders (2011) (0)
- Title Heart rate variability and treatment outcome in major depression : A pilot study Permalink (2014) (0)
- Authors' reply. (2015) (0)
- Author's reply: To PMID 25213159. (2015) (0)
- DIFFERENTIAL THERAPEUTIC RESPONSES TO ANTIDEPRESSANT MEDICATION (1999) (0)
- Patient Management Exercise for Women's Mental Health (2012) (0)
This paper list is powered by the following services:
Other Resources About Ian Cook
What Schools Are Affiliated With Ian Cook ?
Ian Cook is affiliated with the following schools:
